🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsOral GLP-1 AgonistsDanuglipron BID dosing — January 2024 Page 2

Danuglipron BID dosing — January 2024

chris_chi24 Thu, May 16, 2024 at 2:57 PM 6 replies 1,881 viewsPage 2 of 2
BariatricNurseD
Senior Member
1,678
7,234
Feb 2024
Dallas, TX
Online
May 17, 2024 at 12:08 PM#6
Dr.ObesityMed said:
The OASIS programme put 50mg oral in the same territory as 2.4mg injectable — around 15% mean weight loss — but it needed a dose 20 times larger to…

I do not accept that the fasting window is a minor inconvenience. Adherence data on daily orals with timing requirements is consistently worse than weekly injections, and a drug you take imperfectly is a lower dose than the one on the box.

48 18tony_orlando, Dr.NephBHM_UK, kim_atl_prep and 45 others
Reply Quote Save Share Report
DataDave
Senior Member
1,678
8,901
Apr 2024
Washington
Online
May 17, 2024 at 8:33 PM#7

One concrete data point for the thread. The boring version of this is the one that works, and the boring version is: measure a baseline, change one variable, wait, measure again under the same conditions. Nobody wants that answer and it is still the answer.

47 17mike_nyc, VendorMark, COA_Karl and 44 others
Reply Quote Save Share Report
Dr.RenalNash
VIP Member
1,234
7,890
Mar 2024
Nashville, TN
May 18, 2024 at 4:58 AM#8
BariatricNurseD said:
I do not accept that the fasting window is a minor inconvenience.

There is a second half to this that has not been said yet. It is worth asking what the claim would look like if it were false. If nothing would look different, it is not a claim about the world and no amount of discussion will settle it.

Correct me if the detail matters more than I have assumed.

Last edited: May 18, 2024 at 9:58 AM
46 16Dr.NutriCornell, pam_stl, wei_SG and 43 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
greg_boulder
Member
345
1,567
Jul 2024
Boulder, CO
May 18, 2024 at 1:22 PM#9

Following on from PeptideSynthNJ — and this may be the naive question:

How much of the oral variability is the SNAC absorption window and how much is dose, because the two get conflated constantly?

45 15patPC_UT, Dr.DermMIA, fiona_VT and 42 others
Reply Quote Save Share Report
chris_chi24
Member
389
1,678
Sep 2024
Chicago, IL
May 20, 2024 at 5:42 AM#10

OP back with an update, since a thread like this is useless without one.

I moved the tablet to the moment I wake up rather than trying to fit it around breakfast, and the difference in the following weeks was obvious. It was a timing problem, not a dose problem.

15 15SleepFixSam, PurityPaulOR, MaxMetOK and 12 others
Reply Quote Save Share Report

Similar Threads

Orforglipron Phase 3 ATTAIN-1 topline — oral non-peptide GLP-116 replies
Oral semaglutide 50mg (Rybelsus HD) — OASIS program results12 replies
Danuglipron BID dosing — Pfizer oral GLP-1 update7 replies
Oral vs injectable GLP-1: bioavailability and efficacy comparison5 replies
Orforglipron food interaction profile — no fasting requirement15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register